Pepper cuts the risk of colorectal cancers, finds study.
According to the study by researchers at the University of California, San Diego School of Medicine, the active ingredient in chili peppers - produces chronic activation of a receptor on cells lining the intestines of mice, triggering a reaction that ultimately reduces the risk of colorectal tumors.
Exploring the Benefits of Chili Pepper
Capsaicin has been studied for various medicinal properties including anti-coagulant effects. Chilli peppers and capsicums are rich in vitamin A, C and potassium and are extremely low on calories.
Advertisement
The receptor or ion channel, called TRPV1, was originally discovered in sensory neurons, where it acts as a sentinel for heat, acidity and spicy chemicals in the environment.
Eyal Raz said that these are all potentially harmful stimuli to cells, thus TRPV1 was quickly described as a molecular 'pain receptor.' This can be considered to be its conventional function, which all takes place in the nervous system.
![Colorectal Cancer Screening with Double-Contrast Barium Enema]( "Colorectal Cancer Screening with Double-Contrast Barium Enema")
Double-contrast barium enema is a radiological technique that can be used to screen individuals for colorectal cancer and is performed when colonoscopy is not possible.
The scientists discovered that TRPV1, once activated by the EGFR, initiates a direct negative feedback on the EGFR, dampening the latter to reduce the risk of unwanted growth and intestinal tumor development. They found that mice genetically modified to be TRPV1-deficient suffered higher-than-normal rates of intestinal tumor growths.
The study was published in The Journal of Clinical Investigation.
Source: ANI
Colorectal Cancer Screening with Double-Contrast Barium Enema
Double-contrast barium enema is a radiological technique that can be used to screen individuals for colorectal cancer and is performed when colonoscopy is not possible.
Advertisement
The scientists discovered that TRPV1, once activated by the EGFR, initiates a direct negative feedback on the EGFR, dampening the latter to reduce the risk of unwanted growth and intestinal tumor development. They found that mice genetically modified to be TRPV1-deficient suffered higher-than-normal rates of intestinal tumor growths.
The study was published in The Journal of Clinical Investigation.
Source: ANI
Recovery Surgery Following Colorectal Surgery Feasible in a Community Hospital Setting
A recovery program designed for patients who have undergone a colorectal surgery is actually feasible in a community hospital setting
Advertisement
Survival Chances Improved Through TAS-102 in Metastatic Colorectal Cancer Refractory to Standard TherapiesPatients whose metastatic colorectal cancer is refractory to standard therapies benefit from a new combination agent TAS-102. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.
Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.
Examining breast cancer occurrence and stages reveals disparities in urban versus rural rates, influenced by environmental conditions and the stage of the disease.
Polymerases theta and delta assist in the development of new cancer drugs known as polymerase theta inhibitors, currently undergoing clinical trials.